Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective study

Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective study

Abstract Background Although erythropoiesis-stimulating agents (ESAs) have been the standard treatment for renal anemia, ESA hyporesponsiveness remains a concern. Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) are a new class of agents indicated for renal anemia. Several lines of...

Full description

Saved in:
Bibliographic Details
Main Authors: Kohei Odajima, Shigeyuki Arai, Ryo Kido, Hitoshi Anzai, Maika Gojo, Shuntaro Taira, Rena Matsui, Yoshihide Fujigaki, Shigeru Shibata
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Nephrology
Subjects:
CKD
Anemia
HIF-PHI
Erythropoiesis
ESA
Online Access:https://doi.org/10.1186/s12882-024-03877-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12882-024-03877-4

Similar Items